The promising treatment for long COVID we’re not even trying
The Atlantic, May 10, 2022
Early anecdotes about Paxlovid’s effects on long COVID are intriguing, but no one’s testing them in clinical trials yet. Vineet Menachery, a coronavirus expert at the University of Texas Medical Branch, believes long-term infection is probably “more common than we think,” he told Katherine Wu.